Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/25/2025

Treatment of Familial Hypertriglyceridemia

Initial Assessment and Secondary Causes

  • The American College of Cardiology recommends evaluating for uncontrolled diabetes or prediabetes, as poor glycemic control significantly amplifies triglyceride elevation in genetically predisposed individuals 1, 2
  • Screening for hypothyroidism, renal disease, liver disease, and review of medications that can cause massive triglyceride rises in familial hypertriglyceridemia is necessary 1
  • Assessing alcohol intake and eliminating consumption entirely is crucial, as alcohol significantly raises triglyceride levels 1, 2
  • Recognizing that multifactorial chylomicronemia syndrome is 40-60 fold more common than pure monogenic familial chylomicronemia syndrome is important 1

Lifestyle Interventions: The Critical Foundation

  • Targeting 5-10% weight loss, which reduces triglycerides by 20% and in some patients up to 50-70%, is recommended 3, 2
  • Restricting added sugars to <6% of total daily calories and limiting total fat to 30-35% of calories for mild-moderate hypertriglyceridemia is advised 3, 2
  • Engaging in at least 150 minutes per week of moderate-intensity aerobic activity or 75 minutes per week of vigorous-intensity activity is necessary 3
  • Adding resistance training with 8-10 different exercises, 1-2 sets per exercise, 10-15 repetitions at moderate intensity, 2 days per week is recommended 3

Pharmacologic Therapy Algorithm

  • The American College of Cardiology recommends fenofibrate as the first-line pharmacologic agent to reduce pancreatitis risk in severe hypertriglyceridemia (≥500 mg/dL) 1
  • Initiating statin therapy if 10-year ASCVD risk ≥7.5% (moderate-to-high risk) is advised, which provides 10-30% dose-dependent triglyceride reduction 3, 2
  • Targeting non-HDL-cholesterol <130 mg/dL in patients with triglycerides 200-499 mg/dL is recommended 2

Special Considerations for Familial Hypertriglyceridemia

  • Avoiding bile acid sequestrants when triglycerides are >200 mg/dL is necessary, as they are relatively contraindicated 2
  • Exercising caution when combining fibrates with statins due to increased myositis risk, though fenofibrate has a better safety profile than gemfibrozil is crucial 2
  • Monitoring creatine kinase levels when using combination therapy, particularly in patients >65 years of age is recommended 2

Monitoring Strategy

  • Reassessing fasting lipid panel in 6-12 weeks after implementing lifestyle modifications is necessary 3, 2
  • Monitoring lipid levels annually or every 2 years if all values remain optimal (triglycerides <150 mg/dL) is advised 3
  • Re-evaluating for undiagnosed or undertreated secondary causes if triglycerides remain >150 mg/dL despite adherence to lifestyle changes is recommended 3

Treatment of Familial Hypertriglyceridemia with Fenofibrate

Pharmacologic Therapy Algorithm

  • The American Diabetes Association recommends that if triglycerides remain elevated >200 mg/dL after 3 months of optimized lifestyle modifications and statin therapy, consider adding fenofibrate or prescription omega-3 fatty acids (icosapent ethyl 2-4g daily) 4
  • The American Heart Association suggests that fenofibrate has a better safety profile than gemfibrozil when combined with statins, but myositis risk remains increased 5